Evaluating Insulin Formulations on Comparing Effectiveness and Patient-Centered Outcomes

Abstract

Get full access to this article

View all access options for this article.

References

Qayuum

Wilson

Bolen

. Comparative effectiveness, safety, and indications of insulin analogues in premixed formulations for adults with type 2 diabetes. Rockville, MD: Agency for Healthcare Research and Quality. Publication no. 08-EHC017-EF, September 2008. Available at http://www.effectivehealthcare.ahrq.gov/ehc/products/18/106/2008_0915InsulinAnaloguesFinal.pdf.

Miser

Arakaki

Jiang

. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial. Clin Ther. 2010;32:896-908.

Levin

Zhang

Mersey

. Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design. Clin Ther. 2011;33:841-850.

Testa

Gill

. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial. J Clin Endocrinol Metab. 2012;97:3504-3514.